To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome (MDS), overall survival (OS) of 192 children prospectively enrolled in EWOG-MDS studies was evaluated with regard to karyotypic complexity. The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced MDS.